This company seems to have been delisted
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Last recorded trade on: February 19, 2025
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
HK$498.27
Share price
0.00%
Change (1 day)
14.32%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Catalent (CTLT) - Total assets
Total assets on the balance sheet as of September 2024 : HK$76.20 Billion
According to Catalent's latest financial reports the company's total assets are HK$76.20 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Catalent - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-06-30 | HK$84.44 B | 2.41% |
| 2022-06-30 | HK$82.45 B | 16.55% |
| 2021-06-30 | HK$70.74 B | 17.37% |
| 2020-06-30 | HK$60.27 B | 24.77% |
| 2019-06-30 | HK$48.30 B | 35.85% |
| 2018-06-30 | HK$35.56 B | 31.87% |
| 2017-06-30 | HK$26.96 B | 12.43% |
| 2016-06-30 | HK$23.98 B | -1.39% |
| 2015-06-30 | HK$24.32 B | 1.57% |
| 2014-06-30 | HK$23.94 B | 4.69% |
| 2013-06-30 | HK$22.87 B | -6.06% |
| 2012-06-30 | HK$24.35 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Supernus Pharmaceuticals
SUPN | HK$10.57 B | -86.12% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | HK$2.94 B | -96.13% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | HK$90.53 B | 18.82% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | HK$3.08 B | -95.95% | 🇺🇸 USA |